This article requires a subscription to view the full text. You may purchase access to this article or login to access your subscription using the links below.
Abstract
Fecal transplants can make immunotherapy-refractory melanomas sensitive to checkpoint blockade, a finding that highlights the potential of manipulating gut bacteria to boost response rates to anti–PD-1 agents. Yet, how best to modulate the microbiome remains a matter of active debate.
- ©2021 American Association for Cancer Research.
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.